Clinical trials
Phase 2/3 Leukemia, Myeloid, Acute trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Basilea Pharmaceutica | 1 |
| Janssen Research & Development, LLC | 1 |
| Taiho Oncology, Inc. | 1 |
| University Hospital Muenster | 1 |
| University of Ulm | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 6 |
| Leukemia | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Hematologic Diseases | 1 |
| Leukemia, Myeloid | 1 |
| Leukemia, Myelomonocytic, Chronic | 1 |
| Myelodysplastic Syndromes | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.